Fujita K
Department of Urology, National Medical Center Hospital, Tokyo, Japan.
Clin Ther. 1988;10 Spec No:36-42.
Each of 233 patients undergoing transurethral prostatectomy received 2 gm of a cephalosporin intravenously on the day of surgery and the following day and 1 gm on each of the next two days. No serious postoperative complications and no epididymitis were noted. Postoperative urinary tract infections occurred in 7% of the 233 patients: in 13% of the 64 patients preoperatively infected and in 5% of the 169 patients not preoperatively infected. Fourteen previous studies of prophylaxis in transurethral prostatectomy are reviewed.